Korea Investment Corp’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63M Sell
2,614,654
-38,435
-1% -$1.01M 0.12% 163
2026
Q1
$74.5M Sell
2,653,089
-155,144
-6% -$4.13M 0.15% 119
2025
Q4
$69.9M Buy
2,808,233
+9,888
+0.4% +$249K 0.14% 135
2025
Q3
$71.3M Sell
2,798,345
-1,689,216
-38% -$41.7M 0.15% 130
2025
Q2
$109M Buy
4,487,561
+767,323
+21% +$17.9M 0.24% 79
2025
Q1
$94.3M Sell
3,720,238
-556,393
-13% -$14.6M 0.23% 89
2024
Q4
$113M Buy
4,276,631
+465,700
+12% +$12.6M 0.27% 68
2024
Q3
$110M Buy
3,810,931
+42,583
+1% +$1.24M 0.26% 78
2024
Q2
$105M Buy
3,768,348
+135,496
+4% +$3.73M 0.27% 71
2024
Q1
$101M Sell
3,632,852
-341,798
-9% -$9.48M 0.26% 79
2023
Q4
$114M Buy
3,974,650
+667,547
+20% +$20.2M 0.3% 69
2023
Q3
$110M Sell
3,307,103
-1,065,852
-24% -$37.7M 0.32% 60
2023
Q2
$160M Sell
4,372,955
-392,289
-8% -$15.3M 0.45% 40
2023
Q1
$194M Sell
4,765,244
-577,120
-11% -$24.9M 0.57% 32
2022
Q4
$274M Buy
5,342,364
+361,034
+7% +$17.3M 0.86% 20
2022
Q3
$218M Buy
4,981,330
+78,601
+2% +$3.82M 0.67% 25
2022
Q2
$257M Buy
4,902,729
+421,036
+9% +$21.5M 0.79% 22
2022
Q1
$232M Sell
4,481,693
-69,411
-2% -$3.6M 0.57% 26
2021
Q4
$269M Buy
4,551,104
+1,518,117
+50% +$75.2M 0.7% 23
2021
Q3
$130M Buy
3,032,987
+119,523
+4% +$5.29M 0.39% 54
2021
Q2
$114M Sell
2,913,464
-62,155
-2% -$2.42M 0.33% 78
2021
Q1
$108M Buy
2,975,619
+470,694
+19% +$16.7M 0.34% 70
2020
Q4
$92.2M Buy
2,504,925
+151,980
+6% +$5.57M 0.28% 104
2020
Q3
$81.9M Sell
2,352,945
-950,498
-29% -$33.3M 0.29% 87
2020
Q2
$102M Sell
3,303,443
-1,449,566
-30% -$49.2M 0.38% 65
2020
Q1
$147M Sell
4,753,009
-237,677
-5% -$8.1M 0.65% 31
2019
Q4
$186M Buy
4,990,686
+384,816
+8% +$13.7M 0.68% 29
2019
Q3
$157M Buy
4,605,870
+15,072
+0.3% +$548K 0.66% 31
2019
Q2
$189M Sell
4,590,798
-48,906
-1% -$1.94M 0.81% 23
2019
Q1
$187M Buy
4,639,704
+154,977
+3% +$6.21M 0.84% 21
2018
Q4
$186M Sell
4,484,727
-82,633
-2% -$3.43M 1.01% 15
2018
Q3
$191M Sell
4,567,360
-395,841
-8% -$15.2M 0.88% 16
2018
Q2
$171M Buy
4,963,201
+95,071
+2% +$3.25M 0.78% 21
2018
Q1
$164M Sell
4,868,130
-41,195
-0.8% -$1.42M 0.76% 21
2017
Q4
$169M Buy
4,909,325
+582,018
+13% +$19.8M 0.77% 24
2017
Q3
$147M Sell
4,327,307
-112,040
-3% -$3.6M 0.68% 25
2017
Q2
$141M Sell
4,439,347
-216,442
-5% -$6.83M 0.66% 27
2017
Q1
$151M Sell
4,655,789
-1,980,980
-30% -$62.5M 0.75% 21
2016
Q4
$205M Buy
6,636,769
+628,141
+10% +$19.2M 0.98% 13
2016
Q3
$193M Buy
6,008,628
+235,468
+4% +$7.87M 1.03% 12
2016
Q2
$193M Buy
5,773,160
+1,266,908
+28% +$40.4M 1.15% 11
2016
Q1
$127M Sell
4,506,252
-210,273
-4% -$6.01M 0.93% 15
2015
Q4
$144M Buy
4,716,525
+526,157
+13% +$16.6M 1.01% 13
2015
Q3
$125M Buy
4,190,368
+820,308
+24% +$26.3M 0.99% 11
2015
Q2
$107M Sell
3,370,060
-532,270
-14% -$17.3M 0.91% 11
2015
Q1
$129M Buy
3,902,330
+243,369
+7% +$7.74M 1% 10
2014
Q4
$108M Sell
3,658,961
-196,676
-5% -$5.64M 0.89% 14
2014
Q3
$108M Buy
3,855,637
+122,264
+3% +$3.43M 0.88% 16
2014
Q2
$105M Buy
3,733,373
+116,572
+3% +$3.32M 0.88% 16
2014
Q1
$110M Sell
3,616,801
-590,135
-14% -$17.6M 0.98% 13
2013
Q4
$122M Buy
4,206,936
+170,116
+4% +$4.95M 1.16% 8
2013
Q3
$110M Sell
4,036,820
-35,836
-0.9% -$975K 1.17% 7
2013
Q2
$108M Buy
+4,072,656
New +$113M 1.3% 8

Other funds holding PFE

Korea Investment Corp's PFE Position: Q2 2026 in Review

Korea Investment Corp reduced its Pfizer (PFE) stake by 1.4% in Q2 2026, selling an estimated $1.01M and leaving 2,614,654 shares worth $63M. The position accounts for 0.12% of the portfolio, ranked #163.

Korea Investment Corp first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $274M in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Korea Investment Corp held 2,614,654 shares of Pfizer worth $63M as of Q2 2026.
  • Korea Investment Corp sold 38,435 Pfizer shares in Q2 2026, an estimated $1.01M.
  • Pfizer made up 0.12% of Korea Investment Corp's portfolio in Q2 2026, its #163 holding.
  • Korea Investment Corp first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Korea Investment Corp's Pfizer position peaked at $274M in Q4 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Korea Investment Corp's 13F filing for Q2 2026, filed 12 Aug 2026.